Dr. Andreas Hentschel

Acta Neuropathologica Communications, Bd. 13, Nr. 1, 2025

Della Marina A, Rink L, Hentschel A, Schuendeln MM, Nelke C, Koelbel H, Tucht C, Dobelmann V, Ruck T, Hagenacker T, Evangelista T, Schara-Schmidt U,…

Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient

Proteomics, 2025, S. e70003

Behnke J, Hentschel A, Wolf M, Wycisk V, Sickmann A, Heyer RS, Urner LH.

Detergent Screening With Hybrid Detergents Increases Observable Number of Protein Identities in Bottom-Up Proteomics

Journal of Neuromuscular Diseases, Bd. 12, Nr. 2, 2025, S. 271-278

Hentschel A, Lacene E, Brochier G, Boisserie J, Fromes Y, Romero NB, Roos A, Evangelista T.

Glycogenosis type XI, a rare association between muscle and skin manifestations - the contribution of proteomics for the understanding of the underlying myopathology

Frontiers in Molecular Neuroscience, Bd. 18, 2025

Oeztuerk M, Herebian D, Dipali K, Hentschel A, Rademacher N, Kraft F, Horvath R, Distelmaier F, Meuth SG, Ruck T, Schara-Schmidt U, Roos A.

Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegeneration in spastic ataxia type 5

Acta Neuropathologica Communications, Bd. 13, Nr. 1, 2025

Della Marina A, Koutsoulidou A, Natera-de Benito D, Tykocinski L, Tomazou M, Georgiou K, Laner A, Kölbel H, Nascimento A, Ortez C, Abicht A, Thakur…

Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome